BRAINBox Solutions Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Series B3
- Latest Deal Amount
-
$10M
- Investors
-
17
BRAINBox Solutions General Information
Description
Developer of a medical technology platform designed to offer a multi-modality approach to the diagnosis and prognosis of mild traumatic brain injury. The company's platform offers blood biomarker panels for standard laboratory systems (including point-of-care) and neurocognitive testing, producing an artificial intelligence-driven score, enabling the healthcare sector to provide objective answers as to who will recover or have ongoing (and which) symptoms.
Contact Information
Website
www.brainboxinc.comCorporate Office
- 737 North Fifth Street
- Suite 304
- Richmond, VA 23219
- United States
Corporate Office
- 737 North Fifth Street
- Suite 304
- Richmond, VA 23219
- United States
BRAINBox Solutions Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series B3) | 07-Nov-2023 | $10M | Completed | Generating Revenue | ||
| 5. Accelerator/Incubator | Completed | Clinical Trials - Phase 2 | ||||
| 4. Grant | 15-Jun-2022 | Completed | Clinical Trials - Phase 2 | |||
| 3. Early Stage VC (Series A) | 22-Mar-2022 | Completed | Clinical Trials - Phase 2 | |||
| 2. Grant | 21-Mar-2022 | $3.5M | Completed | Clinical Trials - Phase 2 | ||
| 1. Debt - PPP | 16-Apr-2020 | $193K | Completed | Clinical Trials - Phase 2 |
BRAINBox Solutions Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-3 | ||||||||
| Series B-2 | ||||||||
| Series B-1 | 707,683 | $0.010000 | $0.05 | $0.87 | $0.87 | 1x | $0.87 | 1.83% |
| Series A | 20,107,129 | $0.010000 | $0.06 | $1 | $1 | 1x | $1 | 51.91% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
BRAINBox Solutions Comparisons
Industry
Financing
Details
BRAINBox Solutions Competitors (18)
One of BRAINBox Solutions’s 18 competitors is Cepheid, a Formerly VC-backed company based in Sunnyvale, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cepheid | Formerly VC-backed | Sunnyvale, CA | ||||
| ChipCare | Formerly VC-backed | Toronto, Canada | ||||
| Oculogica | Venture Capital-Backed | New Richmond, WI | ||||
| BrainScope | Venture Capital-Backed | Rockville, MD | ||||
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom |
BRAINBox Solutions Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BRAINBox Solutions Patents
BRAINBox Solutions Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025179300-A1 | Biomarkers, compositions, kits, and methods distinguishing acute geriatric tbi from pre-existing dementia or cognitive impairment | Pending | 24-Feb-2024 | ||
| EP-4436467-A1 | Biomarker testing for chronic persistent injury following brain trauma | Pending | 22-Nov-2021 | ||
| EP-4436467-A4 | Biomarker testing for chronic persistent injury following brain trauma | Pending | 22-Nov-2021 | ||
| US-20250035650-A1 | Biomarker testing for chronic persistent injury following brain trauma | Pending | 22-Nov-2021 | ||
| WO-2023092157-A1 | Biomarker testing for chronic persistent injury following brain trauma | Inactive | 22-Nov-2021 | G01N33/6896 |
BRAINBox Solutions Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BRAINBox Solutions Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CAV Angels | Angel Group | Minority | ||
| Virginia Innovation Partnership Corporation | Not-For-Profit Venture Capital | Minority | ||
| Virginia Venture Partners | Venture Capital | Minority | ||
| National Institutes of Health | Government | |||
| Ambit Health Ventures | Venture Capital | Minority |
BRAINBox Solutions FAQs
-
When was BRAINBox Solutions founded?
BRAINBox Solutions was founded in 2018.
-
Where is BRAINBox Solutions headquartered?
BRAINBox Solutions is headquartered in Richmond, VA.
-
What is the size of BRAINBox Solutions?
BRAINBox Solutions has 18 total employees.
-
What industry is BRAINBox Solutions in?
BRAINBox Solutions’s primary industry is Diagnostic Equipment.
-
Is BRAINBox Solutions a private or public company?
BRAINBox Solutions is a Private company.
-
What is the current valuation of BRAINBox Solutions?
The current valuation of BRAINBox Solutions is .
-
What is BRAINBox Solutions’s current revenue?
The current revenue for BRAINBox Solutions is .
-
How much funding has BRAINBox Solutions raised over time?
BRAINBox Solutions has raised $38M.
-
Who are BRAINBox Solutions’s investors?
CAV Angels, Virginia Innovation Partnership Corporation, Virginia Venture Partners, National Institutes of Health, and Ambit Health Ventures are 5 of 17 investors who have invested in BRAINBox Solutions.
-
Who are BRAINBox Solutions’s competitors?
Cepheid, ChipCare, Oculogica, BrainScope, and Oxford Nanopore Technologies are some of the 18 competitors of BRAINBox Solutions.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
